Zelira Therapeutics Ltd (FRA:G1G)
€ 0.464 0.01 (2.2%) Market Cap: 5.64 Mil Enterprise Value: 6.68 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 25/100

Zelira Therapeutics Ltd Annual Shareholders Meeting Transcript

Nov 15, 2023 / 12:30AM GMT
Release Date Price: €0.54 (-3.57%)
Osagie Imasogie
Zelira Therapeutics Limited - Chairman

It is now 8:30 AM in Australia. I am delighted to welcome all shareholders and observers to this Annual General Meeting of Zelira Therapeutics Limited. For those that don't know me, I am Osagie Imasogie, Zelira's Chairman.

The other directors present today are Dr. Oludare Odumosu, our CEO and Managing Director, and he's participating virtually; Tim Slate, our Non-Executive Director and Company Secretary, who in-person in our offices in Perth; Greg Blake, our Executive Director, who's also in-person in our offices in Perth; Dr. Donna Gentile O'Donnell, our Non-Executive Director, who is also participating virtually.

Also present today is a representative from our auditors, HLB Mann Judd, and Wendy Turner from our share registry, Computershare. I will ask all those present to note that the shareholders' register is available for inspection and that the proxies affecting today's resolutions are tabled and are also available for inspection. There is a quorum present, and I declare the meeting open.

Today's meeting is being

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot